NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
- Citation:
- Cancer vol 124 (3) 537-45
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 7
- Parents:
- 2275
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Novartis, Genentech/Roche
- Grants:
- U10CA180821, U10CA180882, CA025224, U10CA180790, UG1CA189825, UG1CA189863, U10 CA180821, U10 CA180882
- Corr. Author:
- Authors:
- Robert R McWilliams Jacob B Allred Jessica A Slostad Rajini Katipamula Roxana S Dronca Kandelaria M Rumilla Lori A Erickson Alan H Bryce Richard W Joseph Lisa A Kottschade David M King John M Leitch Svetomir N Markovic
- Networks:
- IL043, LAPS-MN026, METROMIN, ND010
- Study
- NCCTG-N0879
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- chemotherapy, everolimus, melanoma, uveal